KR20190009849A - Hb9 조절제를 사용하는 인간 배아 줄기세포의 췌장 내분비 세포로의 분화 - Google Patents

Hb9 조절제를 사용하는 인간 배아 줄기세포의 췌장 내분비 세포로의 분화 Download PDF

Info

Publication number
KR20190009849A
KR20190009849A KR1020197002033A KR20197002033A KR20190009849A KR 20190009849 A KR20190009849 A KR 20190009849A KR 1020197002033 A KR1020197002033 A KR 1020197002033A KR 20197002033 A KR20197002033 A KR 20197002033A KR 20190009849 A KR20190009849 A KR 20190009849A
Authority
KR
South Korea
Prior art keywords
cells
cell
tgf
inhibitor
t3
Prior art date
Application number
KR1020197002033A
Other languages
English (en)
Other versions
KR102036780B1 (ko
Inventor
알리레자 레자니아
Original Assignee
얀센 바이오테크 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201261747672P priority Critical
Priority to US61/747,672 priority
Application filed by 얀센 바이오테크 인코포레이티드 filed Critical 얀센 바이오테크 인코포레이티드
Priority to PCT/US2013/075959 priority patent/WO2014105546A1/en
Publication of KR20190009849A publication Critical patent/KR20190009849A/ko
Application granted granted Critical
Publication of KR102036780B1 publication Critical patent/KR102036780B1/ko

Links